MARINUS PHARMACEUTICALS, INC. Annual Interest Expense in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Marinus Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from 2013 to 2023.
  • Marinus Pharmaceuticals, Inc. Interest Expense for the quarter ending March 31, 2024 was $4.35M, a 4.8% increase year-over-year.
  • Marinus Pharmaceuticals, Inc. Interest Expense for the twelve months ending March 31, 2024 was $17.1M, a 30.2% increase year-over-year.
  • Marinus Pharmaceuticals, Inc. annual Interest Expense for 2023 was $16.9M, a 58.3% increase from 2022.
  • Marinus Pharmaceuticals, Inc. annual Interest Expense for 2022 was $10.7M, a 313% increase from 2021.
  • Marinus Pharmaceuticals, Inc. annual Interest Expense for 2021 was $2.58M.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $16.9M +$6.22M +58.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $10.7M +$8.09M +313% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $2.58M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2017 $159K -$305K -65.7% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-12
2016 $464K -$11K -2.32% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-12
2015 $475K +$358K +306% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
2014 $117K +$26K +28.6% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-13
2013 $91K Jan 1, 2013 Dec 31, 2013 10-K 2015-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.